相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study
Lu Xia et al.
PHYTOMEDICINE (2021)
Clinical evaluation of Shufeng Jiedu Capsules combined with umifenovir (Arbidol) in the treatment of common-type COVID-19: a retrospective study
Jing Chen et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2021)
Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management
Liu-Cheng Li et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials
Zuanji Liang et al.
CHINESE MEDICINE (2021)
Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: A national retrospective registry study
Lihua Zhang et al.
PHYTOMEDICINE (2021)
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial
Li Ni et al.
FRONTIERS OF MEDICINE (2021)
A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
Jieqin Zhuang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2021)
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease
Shuang Ji et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The hepatoprotective effects of XCHD and MgIG against methotrexate-induced liver injury and inflammation in rats through suppressing the activation of AIM2 inflammasomes
Chen Chen et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
Zhenwei Wang et al.
BIOSCIENCE TRENDS (2020)
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
Li Ni et al.
FRONTIERS OF MEDICINE (2020)
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Hai-xia Su et al.
ACTA PHARMACOLOGICA SINICA (2020)
Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking
Lin Han et al.
CHINESE MEDICINE (2020)
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
Rafael B. Polidoro et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
Liu-Cheng Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
Siyi Xin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
Ruocong Yang et al.
PHARMACOLOGICAL RESEARCH (2020)
The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
Dan Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
Mingzhong Xiao et al.
PHARMACOLOGICAL RESEARCH (2020)
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
Li Runfeng et al.
PHARMACOLOGICAL RESEARCH (2020)
Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
Caiyun Hu et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
Reflections on treatment of COVID-19 with traditional Chinese medicine
Hua Luo et al.
CHINESE MEDICINE (2020)
Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools
Haijun Xiong et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2020)
Systematic analyses on the potential immune and anti-inflammatory mechanisms of Shufeng Jiedu Capsule against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-caused pneumonia
Zhengang Tao et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study
Nannan Shi et al.
PHARMACOLOGICAL RESEARCH (2020)
Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19
Qi-Dong Xia et al.
CELL PROLIFERATION (2020)
The regulation of complementary and alternative medicine professions in Ontario, Canada
Jeremy Y. Ng
INTEGRATIVE MEDICINE RESEARCH (2020)
Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology
Xiao Chen et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study
Jinfang Ma et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Effect of Maxing Shigan Tang on H1N1 Influenza A Virus-Associated Acute Lung Injury in Mice
Yanchun Zhong et al.
INTERVIROLOGY (2016)
Effect of Shufeng Jiedu capsules as a broad-spectrum antibacterial
Yanyan Bao et al.
BIOSCIENCE TRENDS (2016)
Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition
Wenhui Cui et al.
INFLAMMATION RESEARCH (2015)
Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats
Liucheng Li et al.
PHYTOMEDICINE (2015)
Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats
Liang Xu et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus
Chung-Fan Hsieh et al.
JOURNAL OF ETHNOPHARMACOLOGY (2012)
分享论文
